Physician profile
Conner Moslander
NPI 1114422052
$8,930.57
in general payments reported to CMS, 2019-2025
16 companies · $8,326 in 2025
The $8,326 reported for 2025 was more than what 92% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $76.41 · 2024: $529 · 2025: $8,326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Food and Beverage: $1,881 · Travel and Lodging: $1,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Food and Beverage | $1,881.43 |
| Travel and Lodging | $1,472.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,165.97 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $443.78 | 2024-2025 | Airsupra, Bevespi Aerosphere, Fasenra |
| Glaxosmithkline, LLC. | $192.16 | 2025 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.43 | 2024-2025 | Ofev |
| United Therapeutics Corporation | $183.06 | 2024-2025 | Tyvaso, Tyvaso |
| Genzyme Corporation | $157.79 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $126.77 | 2024-2025 | Dupixent |
| Viatris Specialty LLC | $108.65 | 2025 | Yupelri |
| Abiomed | $86.17 | 2024 | Impella |
| Merck Sharp & Dohme LLC | $84.85 | 2024-2025 | Winrevair, Zerbaxa |
| Bayer Healthcare Pharmaceuticals INC. | $76.41 | 2022 | |
| Mylan Specialty L.P. | $45.93 | 2024 | Yupelri |
| Boston Scientific Corporation | $26.05 | 2025 | Captivator II |
| Amgen INC. | $17.18 | 2025 | Tezspire |
| Abbvie INC. | $15.96 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $15.41 | 2025 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conner Moslander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.